Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-20

Clinical Trial Update: Is Spontaneous Bacterial Peritonitis Still Responding to 3rd Generation Cephalosporins? [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing whether spontaneous bacterial peritonitis still responds to third-generation cephalosporins; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tanta University | Conditions: Primary Bacterial Peritonitis | Phase 3 | Status: UNKNOWN